Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised in-practice evaluation of the influence of patient's understanding of her disease and therapy on persistence and compliance to adjuvant therapy for post-menopausal hormone-sensitive early breast cancer.

Trial Profile

A randomised in-practice evaluation of the influence of patient's understanding of her disease and therapy on persistence and compliance to adjuvant therapy for post-menopausal hormone-sensitive early breast cancer.

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms PACT
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003872).
    • 22 Jun 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Twelve and 24-month follow-up results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top